WINT - Why Windtree Therapeutics (WINT) Stock Is Getting Hammered | Benzinga

Windtree Therapeutics Inc (NASDAQ:WINT) shares are trading lower by 20% to $0.32 during Thursday’s session after the company announced it approved a 1-for-18 reverse stock split of its common stock.

This measure, effective April 19, 2024, aims to increase the market price per share, ensuring compliance with Nasdaq’s minimum bid price requirement. Each 18 shares will be converted into 1 share without altering the stock’s par value.

The split affects all shareholders proportionally and does not change their ownership percentage, with fractional shares rounded up.

See Also: Netflix Stock Is ...

WINT) Stock Is Getting Hammered>Full story available on Benzinga.com